Efficacy and Tolerability of Topiramate in Pediatric Migraine

Pediatric Neurology

Volumn 41, Issue 3, 2009, Pages 167-170

  Cruz, Marcos J ^a   Valencia, Ignacio ^a   Legido, Agustín ^a   Kothare, Sanjeev V ^a   Khurana, Divya S ^a   Yum, Sabrina ^a   Hardison, Huntley H ^a   Melvin, Joseph J ^a   Marks, Harold G ^a  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOPIRAMATE;

ADOLESCENT; ADULT; ANHIDROSIS; ARTICLE; CHEMOPROPHYLAXIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL RECORD REVIEW; MENTAL DETERIORATION; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PARESTHESIA; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADOLESCENT; ANALGESICS; CHILD; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MALE; MIGRAINE DISORDERS; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67949086857     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2009.04.020     Document Type: Article

References (19)

1. Lewis D., Ashwal S., Hershey A., Hirtz D., Yonker M., and Silberstein S. Practice parameter: Pharmacological treatment of migraine headaches in children and adolescents. Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 63 (2004) 2215-2224
2. Powers S.W., and Hershey A.D. Biofeedback for childhood migraine. In: Maria B.L. (Ed). Current management in child neurology. 2nd ed (2002), B.C. Decker, Hamilton, Ontario, Canada 83-85
3. Hershey A.D., Powers S.W., Bentti A.-L., and de Grauw T.J. Characterization and response pattern on children presenting to a multi-disciplinary pediatric headache center using a detailed computer database. Headache 39 (1999) 358
4. Von Seggern R.L., Mannix L.K., and Adelman J.U. Efficacy of topiramate in migraine prophylaxis: A retrospective chart analysis. Headache 42 (2002) 804-809
5. Silberstein S.D., Neto W., Schmitt J., and Jacobs D. Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol 61 (2004) 490-495
6. Hershey A., Powers S., Vockell A., LeCates S., and Kabbouche M. Effectiveness of topiramate in the prevention of childhood headaches. Headache 42 (2002) 810-818
7. Olesen J. The international classification of headache disorders. Cephalalgia 24 Suppl. 1 (2004) 1-160
8. Silberstein S.D., Lipton R.B., and Goadsby P.J. Headache in clinical practice (2002), Martin Dunitz, Ltd., London 130-2
9. Lewis D., Diamond S., Scott D., and Jones V. Prophylactic treatment of pediatric migraine. Headache 44 (2004) 230-237
10. Millichap J., and Yee M. The diet factor in pediatric and adolescent migraine. Pediatr Neurol 28 (2003) 9-15
11. Van den Bergh V., Amery W., and Waelkens J. Trigger factors in migraine: A study conducted by the Belgian Migraine Society. Headache 27 (1987) 191-196
12. Valencia I., Fons C., Kothare S.V., et al. Efficacy and tolerability of topiramate in children younger than 2 years old. J Child Neurol 20 (2005) 667-669
13. Mikaeloff Y., de Saint-Martin A., Mancini J., et al. Topiramate: Efficacy and tolerability in children according to epilepsy syndromes. Epilepsy Res 53 (2003) 225-232
14. French J.A., Kanner A.M., Bautista J., et al. Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62 (2004) 1261-1273
15. Winner P., Gendolla A., Stayer C., et al. Topiramate for migraine prevention in adolescents: A pooled analysis of efficacy and safety. Headache 46 (2006) 1503-1510
16. Lakshmi C.V., Singhi P., Malhi P., and Ray M. Topiramate in the prophylaxis of pediatric migraine: A double-blind placebo-controlled trial. J Child Neurol 22 (2007) 829-835
17. Lewis D., Winner P., Saper J., et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 123 (2009) 924-934
18. Campistol J., Campos J., Casas C., and Herranz J.L. Topiramate in the prophylactic treatment of migraine in children. J Child Neurol 20 (2005) 251-253
19. Gross-Tsur V., and Shalev R. Reversible language regression as an adverse effect of topiramate treatment in children. Neurology 62 (2004) 299-30